Research and Markets: Global Molecular Cytogenetics Market 2014-2018 with Abbott Labs, Affymetrix, Agilent Technologies, F. Hoffmann-La Roche, Illumina & PerkinElmer Dominating
DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/qlg6vd/global_molecular) has announced the addition of the "Global Molecular Cytogenetics Market 2014-2018 with Abbott Labs, Affymetrix, Agilent Technologies, F. Hoffmann-La Roche, Illumina & PerkinElmer Dominating" report to their offering.
“Global Molecular Cytogenetics Market 2014-2018 with Abbott Labs, Affymetrix, Agilent Technologies, F. Hoffmann-La Roche, Illumina & PerkinElmer Dominating”
The Global Molecular Cytogenetics Market will grow at a CAGR of 23.51% to 2018
This report covers the present scenario and the growth prospects of the Global Molecular Cytogenetics market for the period 2014-2018. To calculate the market size, the report considers revenue generated from the sales of products used in molecular cytogenetics. The products employed in the use of FISH and aCGH techniques are considered within the scope of the report.
The increase in the incidence of genetic disorders is one of the major drivers. Genetic disorders such as Down syndrome, fragile X syndrome, tuberous sclerosis, and other genetic and chromosomal disorders have increased the demand for cytogenetic diagnostic kits and technology.
Molecular cytogenetic techniques can be used in personalized medicines for the early detection of diseases and selection of appropriate treatment, integration of molecular diagnostics with therapeutics, and monitoring therapy, as well as determining the prognosis. At present, cytogenetic analysis allows the study of essential biological problems such as the nature of inherited syndromes and genomic variations, which are responsible for carcinogenesis and 3D organization of the human genome. Identification and validation of the genetic composition of an individual plays a major part in ascertaining health and susceptibility to common diseases such as heart disease and cancer. The awareness of genetic diseases is helping in the development of personalized medicines, which are focused on targeted drug development. Genetic profiling of patients helps in defining an individual's risk for clinical outcomes and his/her response to specific drugs. Personalized medicines are highly effective and help improve the health of a patient.
Further, the report states that one of the major challenges in the market is the lack of knowledge about genomics among doctors and researchers, which leads to misinterpretation of the genetic data of an individual.
- Abbott Laboratories
- Affymetrix Inc.
- Agilent Technologies Inc.
- F. Hoffmann-La Roche Ltd
- Illumina Inc.
- PerkinElmer Inc.
Key Topics Covered:
- Executive Summary
- List of Abbreviations
- Scope of the Report
- Market Research Methodology
- Market Landscape
- Market Segmentation by Application
- Market Segmentation by Technology
- Geographical Segmentation
- Buying Criteria
- Market Growth Drivers
- Drivers and their Impact
- Market Challenges
- Impact of Drivers and Challenges
- Market Trends
- Trends and their Impact
- Vendor Landscape
- Key Vendor Analysis
For more information visit http://www.researchandmarkets.com/research/qlg6vd/global_molecular